Selected article for: "antiviral signaling and host immunity"

Author: Yang, Bo; Zhang, Ge; Qin, Xiao; Huang, Yulu; Ren, Xiaowen; Sun, Jingliang; Ma, Shujun; Liu, Yanzi; Song, Di; Liu, Yue; Cui, Yuhan; Wang, Hui; Wang, Jie
Title: Negative Regulation of RNF90 on RNA Virus-Triggered Antiviral Immune Responses Targeting MAVS
  • Cord-id: ede64p90
  • Document date: 2021_8_27
  • ID: ede64p90
    Snippet: The antiviral innate immunity is the first line of host defense against viral infection. Mitochondrial antiviral signaling protein (MAVS, also named Cardif/IPS-1/VISA) is a critical protein in RNA virus-induced antiviral signaling pathways. Our previous research suggested that E3 ubiquitin-protein ligases RING-finger protein (RNF90) negatively regulate cellular antiviral responses by targeting STING for degradation, though its role in RNA virus infection remains unknown. This study demonstrated
    Document: The antiviral innate immunity is the first line of host defense against viral infection. Mitochondrial antiviral signaling protein (MAVS, also named Cardif/IPS-1/VISA) is a critical protein in RNA virus-induced antiviral signaling pathways. Our previous research suggested that E3 ubiquitin-protein ligases RING-finger protein (RNF90) negatively regulate cellular antiviral responses by targeting STING for degradation, though its role in RNA virus infection remains unknown. This study demonstrated that RNF90 negatively regulated RNA virus-triggered antiviral innate immune responses in RNF90-silenced PMA-THP1 cells, RNF90-deficient cells (including HaCaTs, MEFs, and BMDMs), and RNF90-deficient mice. However, RNF90 regulated RNA virus-triggered antiviral innate immune responses independent of STING. RNF90 promoted K48-linked ubiquitination of MAVS and its proteasome-dependent degradation, leading to the inhibition of innate immune responses. Altogether, our findings suggested a novel function and mechanism of RNF90 in antiviral innate immunity.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and luciferase assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute respiratory syndrome and luciferase reporter: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and luciferase reporter gene assay: 1
    • acute respiratory syndrome and lung destruction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome and lys residue: 1
    • acute respiratory syndrome and lysine residue: 1, 2, 3, 4, 5
    • acute respiratory syndrome and lysis buffer: 1, 2, 3
    • luciferase assay and lysis buffer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • luciferase reporter and lysine residue: 1
    • luciferase reporter and lysis buffer: 1, 2, 3, 4, 5, 6, 7, 8